across

Akkodis unveils real-world impact of AI-led innovation across industries

From life sciences to financial services and IT operations, Akkodis demonstrates how applied AI is driving measurable business outcomes, enabling…

2 months ago

Senores Pharma Reports Strong Q2 & H1 FY26 Performance, Sustains Growth Momentum Across Businesses

AHMEDABAD, India, Nov. 7, 2025 /PRNewswire/ -- Senores Pharmaceuticals Limited continued its strong growth trajectory in the second quarter of FY26,…

2 months ago

Evergy Selects Kigen To Strengthen Grid Resilience Across Private and Public Networks

Evergy Selects Kigen's Secure eSIM OS and eIM to Maximize Grid Reliability with Automated Failover Across Private and Public Networks…

2 months ago

SBI Life’s ‘Thanks-A-Dot’ sets a GUINNESS WORLD RECORDS, making breast health a living room conversation across communities

With a breast self-examination mosaic made of a record 1,191 'Hug of Life' bags, SBI Life's Guinness World Record promotes…

2 months ago

Thunes Powers the Next Generation of Global Money Movement with Instant Payouts in Stablecoins Across 130+ Countries

By integrating fiat and stablecoin rails in one API, Thunes sets a new global standard for real-time, borderless money movement,…

2 months ago

Cullinan Therapeutics Shares Additional Preclinical B Cell Depletion Data for CLN-978, Supporting Clinical Development Across Multiple Autoimmune Diseases, at ACR Convergence 2025

October 25, 2025 11:01 ET  | Source: Cullinan Therapeutics, Inc. CLN-978 led to rapid and deep B cell depletion in…

2 months ago

ITM Announces Analyses from Phase 3 COMPETE Data Showing Higher Objective Response Rates with n.c.a. 177Lu-edotreotide (ITM-11) vs. Everolimus Across Subgroups of Patients with GEP-NETs at NANETS 2025 Annual Symposium

Austin, Texas, October 25, 2025 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, announced analyses data…

2 months ago

PMV Pharmaceuticals Announces Updated Rezatapopt Monotherapy Interim Data From Ongoing PYNNACLE Phase 2 Trial Across Multiple Solid Tumors With a TP53 Y220C Mutation

October 24, 2025 11:39 ET  | Source: PMV Pharmaceuticals, Inc. Data presented today as an oral presentation at 2025 AACR-NCI-EORTC…

2 months ago

Joget Unlocks Autonomous Productivity Across HR, Procurement, Customer Service, and Supply Chain with No-Code AI Agent Builder

Joget AI Agent Builder enables teams across every department to create goal-driven agents that execute autonomously, yet remain governed by…

2 months ago

Pharming Group announces presentations at 2025 ACAAI Annual Scientific Meeting showcasing new data across rare disease portfolio

Leiden, the Netherlands, October 20, 2025: Pharming Group N.V. (“Pharming” or “the Company”) (Euronext: PHARM; Nasdaq: PHAR) today announced that 12…

2 months ago